Search
25/08/2025
Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes
Viñals, C, Conget, I, Granados, M, Solà, C, Ayala, D, Mesa, A, Seres-Noriega, T, Domenech, M, Perea, V, Blanco, J, Vinagre, I, Gimenez, M, Amor, AJ. Factors Involved in the Progression of Preclinical Atherosclerosis in People with Type 1 Diabetes. Journal of Clinical Medicine. 2025; 14(17)DOI:10.3390/jcm14176004. PMID:40943764. IF:2.900(Q1/2D).
23/08/2025
Neural correlates of human fear conditioning and sources of variability in 2199 individuals
Radua, J, Savage, HS, Vilajosana, E, Jamieson, A, Abler, B, Åhs, F, Beckers, T, Cardoner, N, Cisler, JM, Diniz, JB, Bach, DR, Elsenbruch, S, Greening, SG, Holt, DJ, Kaczkurkin, AN, Keil, A, Kindt, M, Koch, K, LaBar, KS, Lam, CL, Larson, CL, Lonsdorf, TB, Merz, CJ, McLaughlin, KA, Neria, Y, Pine, DS, van Reekum, CM, Shackman, AJ, Soriano-Mas, C, Spoormaker, VI, Stout, DM, Straube, B, Straube, T, Tuominen, L, Visser, RM, Ahumada, L, Arolt, V, Batistuzzo, MC, Bazán, PR, Biggs, EE, Cano, M, Chavarría-Elizondo, P, Cooper, SE, Dannlowski, U, de la Peña-arteaga, V, Decross, SN, Domschke, K, Ehlers, MR, Graner, JL, Hamm, AO, Herrmann, MJ, Huggins, AA, Icenhour, A, Juaneda-Seguí, A, Junghoefer, M, Kircher, T, Koelkebeck, K, Kuhn, M, Labrenz, F, Lissek, SM, Lotze, M, Lueken, U, Margraf, J, Martínez-Zalacaín, I, Moeck, R, Morriss, J, Ortuño, M, Pittig, A, Porta-Casteras, D, Richter, J, Ridderbusch, IC, Rief, W, Roesmann, K, Rosén, J, Russmann, AN, Sjouwerman, R, Spohrs, J, Ströhle, A, Suarez-Jimenez, B, Ulrich, M, Wittchen, HU, Zhu, X, Waller, L, Walter, H, Thompson, PM, Bas-Hoogendam, JM, Groenewold, NA, Stein, DJ, van der Wee, NJ, Dunsmoor, JE, Marquand, AF, Harrison, BJ, Fullana, MA. Neural correlates of human fear conditioning and sources of variability in 2199 individuals. Nature Communications. 2025; 16(1)DOI:10.1038/s41467-025-63078-x. PMID:40849409. IF:15.700(Q1/1D).
22/08/2025
Reward-related neural activation during social media exposure in young women with non-suicidal self-injury: evidence for a continuum of severity in the reward network
Nicolaou, S, Julià, A, Otero, D, Schmidt, C, Pascual, JC, Soler, J, Marco-Pallarés, J, Vega, D. Reward-related neural activation during social media exposure in young women with non-suicidal self-injury: evidence for a continuum of severity in the reward network. Translational Psychiatry. 2025; 15(1)DOI:10.1038/s41398-025-03536-8. PMID:40846692. IF:6.200(Q1/1D).
22/08/2025
Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis
Cantó, E, del Prado, ME, Vilarrasa, E, López-Ferrer, A, de Aranibar, FJGL, Ortiz, MA, Gut, M, Mulet, M, Esteve-Codina, A, Osuna-Gómez, R, Guinart-Cuadra, A, Puig, L, Vidal, S. Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in Psoriasis. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2025; 26(17)DOI:10.3390/ijms26178118. PMID:40943056. IF:4.900(Q1/3D).
21/08/2025
Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum
Rennie, A, Nemy, M, Jerele, C, Rodríguez-Baz, I, Montal, V, Bejanin, A, Kramberger, MG, Aarsland, D, Fortea, J, Lleó, A, Westman, E, Alcolea, D, Ferreira, D. Regional associations between cerebrovascular disease and cholinergic white matter pathways in the Lewy body continuum. npj Parkinsons Disease. 2025; 11(1)DOI:10.1038/s41531-025-01118-5. PMID:40841717. IF:8.200(Q1/1D).
20/08/2025
Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial
Rodríguez-Molinero, A, Pérez-López, C, Caballol, N, Buongiorno, M, Rivera, MAA, Ariztegui, NL, López-Manzanares, L, Hernández-Vara, J, Bayes-Rusiñol, A, Carreró, AG, Saúco, MA, Gomez, EF, Pérez-Martínez, DA, Arroyo, SE, Martí-Martínez, S, Mir, P, Juan, JMS, Martínez-Castrillo, JC, Tebé, C. Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial. npj Parkinsons Disease. 2025; 11(1)DOI:10.1038/s41531-025-00977-2. PMID:40835832. IF:8.200(Q1/1D).